Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Valion Bio (TIVC) Capital Expenditures (2022 - 2025)

Valion Bio has reported Capital Expenditures over the past 3 years, most recently at $25000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures changed N/A year-over-year to $25000.0; the TTM value through Dec 2025 reached $35000.0, up 45.83%, while the annual FY2025 figure was $38000.0, N/A changed from the prior year.
  • Capital Expenditures for Q4 2025 was $25000.0 at Valion Bio, up from $10000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $94000.0 in Q1 2023 and troughed at $5000.0 in Q3 2022.
  • A 3-year average of $27333.3 and a median of $17000.0 in 2023 define the central range for Capital Expenditures.
  • On a YoY basis, Capital Expenditures climbed as much as 1466.67% in 2023 and fell as far as 1466.67% in 2023.
  • Year by year, Capital Expenditures stood at $5000.0 in 2022, then soared by 380.0% to $24000.0 in 2023, then rose by 4.17% to $25000.0 in 2025.
  • Business Quant data shows Capital Expenditures for TIVC at $25000.0 in Q4 2025, $10000.0 in Q3 2025, and $24000.0 in Q2 2023.